Seattle-based company developing therapies for hearing loss and balance disorders, with products sold to healthcare providers.
Founded in 2001 and headquartered in Seattle, US, Sound Pharmaceuticals, Inc. develops therapies for auditory and vestibular health, including hearing loss and balance disorders. The company's CEO is Jonathan Kil. It has engaged in 6 deals, and its most recent funding round was a Series C raising USD 8.41 mn on May 24, 2018. Its products are distributed in North America, Europe and Asia to healthcare providers, from small practices to large hospitals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in